ID

26789

Descripción

Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00893061

Link

https://clinicaltrials.gov/show/NCT00893061

Palabras clave

Versiones (1)
  1. 24/10/17 24/10/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

24 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00893061

Inglés

Eligibility Breast Cancer NCT00893061

1 formularios  
Criteria
Descripción

Criteria

histologically confirmed breast cancer
Descripción

Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
no metastatic disease
Descripción

Exclusion Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0027627
meets criteria for initiating adjuvant endocrine therapy
Descripción

Hormone Therapy Adjuvant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C1522673
hormone receptor status:
Descripción

Hormone Receptor Status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
estrogen receptor- and/or progesterone receptor-positive disease
Descripción

Disease Estrogen receptor positive | Disease Progesterone receptor positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0279754
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0279759
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
postmenopausal, defined as no menstruation for ≥ 1 year, confirmed by a measurement of fsh and 17-beta-estradiol
Descripción

Postmenopausal state | Menstruation absent Duration FSH measurement | Menstruation absent Duration Estradiol Measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2,1]
C0497456
UMLS CUI [2,2]
C0449238
UMLS CUI [2,3]
C0202022
UMLS CUI [3,1]
C0497456
UMLS CUI [3,2]
C0449238
UMLS CUI [3,3]
C0014912
UMLS CUI [3,4]
C0242485
karnofsky performance status 80-100%
Descripción

Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
native speaker of french
Descripción

Native speaker French language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0814951
UMLS CUI [1,2]
C0376246
beneficiary of a french social security insurance plan
Descripción

Insurance Beneficiary Social Security

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3853043
UMLS CUI [1,2]
C0037435
no prior cognitive disorders
Descripción

Exclusion | Cognition Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C0009241
no depression or other confirmed active psychiatric disease
Descripción

Exclusion Criteria | Depressive disorder | Mental disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0011581
UMLS CUI [3]
C0004936
able to undergo the medical monitoring of the trial due to geographic, social or psychological reasons
Descripción

Monitoring Receive Ability

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516647
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C0085732
no personal or family history of thromboembolic disease
Descripción

Exclusion Criteria | Thromboembolism | Family history Thromboembolism

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0040038
UMLS CUI [3,1]
C0241889
UMLS CUI [3,2]
C0040038
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
no prior adjuvant chemotherapy
Descripción

Exclusion Adjuvant Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0085533
no concurrent follow-up participation on another study
Descripción

Exclusion | Study Subject Participation Status | Clinical Study Follow-up

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C2348568
UMLS CUI [3]
C3274571
no concurrent treatment with psychotropic substances (i.e., long half life benzodiazepines, antipsychotics, anticholinesterase)
Descripción

Exclusion Criteria | Psychotropic Drugs | Benzodiazepines | Antipsychotic Agents | Cholinesterase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0033978
UMLS CUI [3]
C0005064
UMLS CUI [4]
C0040615
UMLS CUI [5]
C0008425
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00893061

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Breast Carcinoma
Item
histologically confirmed breast cancer
boolean
C0678222 (UMLS CUI [1])
Exclusion Neoplasm Metastasis
Item
no metastatic disease
boolean
C2828389 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Hormone Therapy Adjuvant
Item
meets criteria for initiating adjuvant endocrine therapy
boolean
C0279025 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Disease Estrogen receptor positive | Disease Progesterone receptor positive
Item
estrogen receptor- and/or progesterone receptor-positive disease
boolean
C0012634 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Postmenopausal state | Menstruation absent Duration FSH measurement | Menstruation absent Duration Estradiol Measurement
Item
postmenopausal, defined as no menstruation for ≥ 1 year, confirmed by a measurement of fsh and 17-beta-estradiol
boolean
C0232970 (UMLS CUI [1])
C0497456 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0202022 (UMLS CUI [2,3])
C0497456 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
C0014912 (UMLS CUI [3,3])
C0242485 (UMLS CUI [3,4])
Karnofsky Performance Status
Item
karnofsky performance status 80-100%
boolean
C0206065 (UMLS CUI [1])
Native speaker French language
Item
native speaker of french
boolean
C0814951 (UMLS CUI [1,1])
C0376246 (UMLS CUI [1,2])
Insurance Beneficiary Social Security
Item
beneficiary of a french social security insurance plan
boolean
C3853043 (UMLS CUI [1,1])
C0037435 (UMLS CUI [1,2])
Exclusion | Cognition Disorders
Item
no prior cognitive disorders
boolean
C2828389 (UMLS CUI [1])
C0009241 (UMLS CUI [2])
Exclusion Criteria | Depressive disorder | Mental disorders
Item
no depression or other confirmed active psychiatric disease
boolean
C0680251 (UMLS CUI [1])
C0011581 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
Monitoring Receive Ability
Item
able to undergo the medical monitoring of the trial due to geographic, social or psychological reasons
boolean
C1516647 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Exclusion Criteria | Thromboembolism | Family history Thromboembolism
Item
no personal or family history of thromboembolic disease
boolean
C0680251 (UMLS CUI [1])
C0040038 (UMLS CUI [2])
C0241889 (UMLS CUI [3,1])
C0040038 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Exclusion Adjuvant Chemotherapy
Item
no prior adjuvant chemotherapy
boolean
C2828389 (UMLS CUI [1,1])
C0085533 (UMLS CUI [1,2])
Exclusion | Study Subject Participation Status | Clinical Study Follow-up
Item
no concurrent follow-up participation on another study
boolean
C2828389 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C3274571 (UMLS CUI [3])
Exclusion Criteria | Psychotropic Drugs | Benzodiazepines | Antipsychotic Agents | Cholinesterase Inhibitors
Item
no concurrent treatment with psychotropic substances (i.e., long half life benzodiazepines, antipsychotics, anticholinesterase)
boolean
C0680251 (UMLS CUI [1])
C0033978 (UMLS CUI [2])
C0005064 (UMLS CUI [3])
C0040615 (UMLS CUI [4])
C0008425 (UMLS CUI [5])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial